Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations
Related PFE
5 U.S. Large-Caps Facing Declining Revenue
Icagen Re-launched Through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D
Baxalta: A Spin-Off That Could Be Revalued Up To 50% Higher (Seeking Alpha)
Related GRMN
Garmin Victorious over Navico in ITC Patent Infringement Case
Wearable Tech Is Wowing The Market

Analysts at Deutsche Bank initiated coverage on Pfizer (NYSE: PFE) with a Buy rating. The target price for Pfizer is set to $34. Pfizer's shares closed at $29.21 yesterday.

Baird initiated coverage on shares of Garmin (NASDAQ: GRMN) with a Neutral rating. The target price for Garmin is set to $59. Garmin's shares closed at $57.46 yesterday.

Analysts at DA Davidson initiated coverage on shares of Oracle (NASDAQ: ORCL) with a Neutral rating. The target price for Oracle is set to $46. Oracle's shares closed at $41.84 yesterday.

Analysts at Jefferies initiated coverage on MannKind (NASDAQ: MNKD) with a Buy rating. The target price for MannKind is set to $10. MannKind's shares closed at $7.34 yesterday.

Latest Ratings for PFE

DateFirmActionFromTo
Jun 2015Piper JaffrayInitiates Coverage onOverweight
Jun 2015JefferiesInitiates Coverage onOverweight
Apr 2015Deutsche BankMaintainsBuy

View More Analyst Ratings for PFE
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (GRMN + MNKD)

Around the Web, We're Loving...

Get Benzinga's Newsletters